Yakup Ergün

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

Yakup Ergün
Jan 19, 2025, 04:13 | Insight
Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer
A recent paper by Charles Geyer Jr., Chief Scientific Officer of NSABP Foundation, was mentioned…
Jan 18, 2025, 07:33 | Insight
NCCN Guidelines Insights: Lung Cancer Screening, Version 1.2025
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared the most recent NCCN guidelines for…
Jan 15, 2025, 17:19 | Insight
Yakup Ergün: A Perspective on the MARS2 Trial by Eric Lim et al
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X: “A Perspective on the…
Jan 15, 2025, 14:03 | Science
A pan‐tumor review of the role of poly (adenosine diphosphate ribose) polymerase inhibitors
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared an article by Chadi Hage Chehade, on…
Jan 14, 2025, 02:50 | Blog
Phase 1b study of telisotuzumab vedotin in combination with osimertinib for NSCLC
Yakup Ergün Medical Oncologist at Antalya City Hospital shared on X: "Results from a phase…
Jan 11, 2025, 09:17 | Blog
Neoadjuvant Nivo+ Ipi vs ChT in Resectable NSCLC
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X: "Neoadjuvant Nivo+ Ipi vs…
Jan 8, 2025, 10:24 | Science
Molecular landscape, challenges and strategies of pulmonary neuroendocrine neoplasms
A recent paper by Triparna Sen, Associate Professor at the Icahn School of Medicine at…
Jan 7, 2025, 09:46 | Science
Glecirasib in KRASG12C-mutated non-small cell lung cancer by Yuankai Shi et al.
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared a post on X about a…
Jan 5, 2025, 16:03 | Science
Yakup Ergün: Metronomic Capecitabine Plus AI as Initial Therapy in HR+/HER2- mBC by Ruo-Xi Hong et al.
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared a post on X about a…
Jan 3, 2025, 19:38 | Blog
Yakup Ergün: 2024 FDA approvals
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared a post on X: “2024 FDA…
Jan 3, 2025, 16:22 | Science
Expert consensus statement on the peri-operative management of NSCLC by Stephanie Saw et al.
A recent article by Stephanie Saw et al. was mentioned by Yakup Ergün, Medical Oncologist at…
Jan 2, 2025, 15:54 | Blog
Yakup Ergün: Final Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared a post on X: "Final, 10-Year…
Dec 30, 2024, 00:49 | Blog
Yakup Ergün: My plan for 2025 - I will no longer review journals that charge APCs
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared a post on X: "My plan…
Dec 20, 2024, 15:57 | Blog
Yakup Ergün: Ponsegromab for the Treatment of Cancer Cachexia
Yakup Ergün, Medical Oncologist at Bower Hospital, shared an by John D. Groarke et al.…
Dec 19, 2024, 11:54 | Opinion
Lung Cancer Trial Highlights from 2024 By Yakup Ergün
Yakup Ergün, Medical Oncologist at Antalya City Hospital, posted on X: “What happened in Lung…
Dec 19, 2024, 01:56 | Science
ESMO Clinical Practice Guideline interim update on the management of biliary tract cancer
An article was published on ESMO Open by A. Vogel and M. Ducreux, titled "ESMO…
Dec 17, 2024, 20:31 | Blog
Outcomes and Trends in Axillary Management of Stage cN3b Breast Cancer Patients
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X: “Outcomes and Trends in…
Dec 17, 2024, 13:22 | Science
A summary of important studies in breast cancer from 2024 by Yakup Ergün
Yakup Ergün, Medical Oncologist at Antalya City Hospital, posted on X: "What happened in breast…
Dec 14, 2024, 17:00 | Insight
Insights on PATINA trial from SABCS 2024
Pre-clinical data showed that CDK 4/6 inhibition plays a role in HER2+ disease. Phase 2…
Dec 12, 2024, 20:33 | Blog
Yakup Ergün: ESMO Magnitude of Clinical Benefit Scale
Yakup Ergün, Medical Oncologist at Bower Hospital, shared a post on X: "European Society for…
Dec 12, 2024, 16:50 | Insight
Imlunestrant and Abemaciclib: A Study in Advanced Breast Cancer
Imlunestrant has been approved for the treatment of breast cancer. It is a next-generation, brain-penetrant,…
Dec 8, 2024, 13:15 | Insight
Yakup Ergün: What is the best time of the month to treat Breast Cancer?
Yakup Ergün, Medical Oncologist at Bower Hospital, shared an article by Wendy V. Ingman on…
Dec 7, 2024, 10:43 | Insight
Pembrolizumab vs Chemotherapy in microsatellite instability – high or mismatch repair – deficient metastatic colorectal cancer
Yakup Ergün, Medical Oncologist at Bower Hospital, shared a recent article by T. André on…
Dec 5, 2024, 09:37 | Blog
Tremelimumab and durvalumab for MSI-H gastric cancer
Yakup Ergün, Medical Oncologist at Bower Hospital, shared a paper by Raimondi et al. on…
Dec 4, 2024, 19:03 | Insight
Residual Disease as a Target for Liquid Biopsy in Patients with Solid Tumours
Yakup Ergün, Medical Oncologist at Bower Hospital, shared a recent article by Klaus Pantel on…
Dec 2, 2024, 09:46 | Positive
Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024
As November came to a close, it's an ideal time to reflect on Lung Cancer…
Nov 30, 2024, 22:15 | Blog
Evaluating Pregabalin for Chronic Cough in Lung Cancer
Yakup Ergün, Medical Oncologist at Bower Hospital, shared a post on X: “Pregabalin for chronic cough…
Nov 30, 2024, 14:02 | Insight
First Results of the Dutch SONIA Trial on CDK4/6 Inhibitors
Evaluating the Impact of CDK4/6 Inhibitors in First- and Second-Line Endocrine Therapy for HR+, HER2-…
Nov 22, 2024, 21:11 | Drugs
Yakup Ergün: Drugs with high and moderate emetogenic potential
Yakup Ergün, Medical Oncologist at Bower Hospital, shared a post on X: “List of drugs…
Nov 18, 2024, 09:53 | Insight
Yakup Ergün: A great article discussing the optimal use of PARP inhibitors by Valentina Tuninetti
Yakup Ergün, Medical Oncologist at Bower Hospital, shared an article by V. Tuninetti, Oncologist at…
Nov 15, 2024, 12:02 | Insight
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Bladder Cancer
Yakup Ergün, Medical Oncologist at Bower Hospital, shared a post on X: "Perioperative Durvalumab with…
Nov 13, 2024, 15:39 | Blog
Yakup Ergün: An eye-opening case report for Oral propranolol for amivantamab-induced scalp ulcers
Yakup Ergün, Medical Oncologist at Bower Hospital, shared a post on X about a recent paper…
Nov 10, 2024, 15:41 | Insight
Yakup Ergün: The era of anthracycline-based chemotherapy in early breast cancer is fading
A recent paper by Thomas Grinda, Clinical Research Fellow at Dana-Farber Cancer Institute, was mentioned…
Nov 4, 2024, 16:23 | Blog
Jan Král: Insights on how genetic mutations vary by cancer type by Yakup Ergün
Jan Král, Gastroenterologist at the Institute for Clinical and Experimental Medicine in Prague, shared a…
Nov 3, 2024, 16:08 | Insight
Yakup Ergün: Benefit of systemic therapy in MINDACT patients with small ER+ HER2- Breast Cancer
Yakup Ergün, Medical Oncologist at Bower Hospital, shared a post on X about a recent…
Nov 1, 2024, 17:05 | Blog
Yakup Ergün: Personalizing Treatment Decisions for Locally Advanced Rectal Cancer
Yakup Ergün, Medical Oncologist at Antalya City Hospital, posted on X about recent paper by…
Oct 15, 2024, 17:36 | Blog
Yakup Ergün: Classification of Ovarian Epithelial Tumors
Yakup Ergün, Medical Oncologist at Bower Hospital, shared on X: "Classification of Ovarian Epithelial Tumors…
Oct 12, 2024, 00:25 | Blog
Yakup Ergün: A drug that neither prolongs life nor improves quality of life is not considered successful
Yakup Ergün, Medical Oncologist at Bower Hospital, shared on X: '' Each paragraph can be…
Oct 4, 2024, 15:04 | Insight
Yakup Ergün: Curative ICIs therapy in patients with dMMR locally advanced rectal cancer
Yakup Ergün, Medical Oncologist at Bower Hospital, shared on X: “Curative ICIs therapy in patients…
Sep 30, 2024, 16:15 | Insight
Yakup Ergün: Rising costs of cancer medicines
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared a post on X about a…
Sep 26, 2024, 14:34 | Blog
Yakup Ergun: Survival and recurrence rates following SBRT or surgery in operable Stage I NSCLC
Yakup Ergun, Medical Oncologist at Antalya City Hospital, shared a post on X, about recent…
Sep 20, 2024, 08:16 | Blog
Yakup Ergün: Nivolumab/Relatlimab or Nivolumab/Ipilimumab in TNBC
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X: "Neoadjuvant nivolumab/relatlimab or nivolumab/ipilimumab in…
Sep 7, 2024, 05:34 | Blog
Survival Outcomes in Real-World Settings After Alternative Pembrolizumab Dosing for NCSLC
Yakup Ergün, Medical Oncologist at Bower Hospital, shared a post on X, about recent paper…
Aug 29, 2024, 03:10 | Insight
ASCO Guideline Clinical Insights: Metastatic Hormone Receptor–Positive Breast Cancer
Yakup Ergün, Medical Oncologist at Bower Hospital, shared on X: "Targeted Therapies, Sequencing Strategies, and…
Aug 9, 2024, 02:14 | Insight
T-DXd in HER2 - Expressing Biliary Tract Cancer
Yakup Ergün, Medical Oncologist at Batman World Hospital, shared on X about a recent paper…
Aug 8, 2024, 20:04 | Insight
Yakup Ergün: Is completion axillary lymph node dissection necessary for adjuvant CDK4/6 inhibitors?
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X: “SENOMAC post-hoc analysis: Is…
Jul 28, 2024, 06:21 | Blog
Yüksel Ürün: The terms 'manageable' and 'acceptable' can be misleading
Yüksel Ürün shared a post by Yakup Ergün, Medical Oncologist at Antalya City Hospital, on…
Jul 27, 2024, 14:16 | Insight
Foritinib in advanced ROS1-rearranged NSCLC in China
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared a post on X about a…
Jul 27, 2024, 13:03 | Blog
Yakup Ergün: Can we truly label a study with Grade 5 toxicity as 'acceptable' or 'manageable'?
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X: "Can we truly label…
Jul 25, 2024, 07:47 | Insight
HER2-targeted therapies beyond breast cancer
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared a post on X about a…
Jul 21, 2024, 21:49 | Blog
Dose-Dense vs Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X, about a recent paper…
Jul 10, 2024, 16:42 | Blog
Yakup Ergün: The effects of 960 mg sotorasib
Tejas Patil, Thoracic oncologist CU Cancer Center, shared a post by Yakup Ergün, Medical Oncologist at Antalya…
Jul 8, 2024, 19:24 | Blog
Yakup Ergün: PRODIGE 23: Long-term results
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared insight about a study by Thierry…
Jun 22, 2024, 13:55 | Insight
"Why do patients with cancer die?" by Adrienne Boire et al.
Recently, Thomas R. Cox, Lab Head of Matrix and Metastasis Lab, shared a post on…
Jun 22, 2024, 13:36 | Blog
Primary Results From AMEERA-5
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X: "Amcenestrant Plus Palbociclib vs Letrozole…
Jun 20, 2024, 16:17 | Blog
Yakup Ergün: My observations over the past few years as a reviewer
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared a post on X: "My observations…
Jun 16, 2024, 15:51 | Insight
Yakup Ergün: CF, DCF, or CF combined with radiotherapy for squamous cell oesophageal cancer
Yakup Ergün, Medical Oncologist at Antalya City Hospital, recently shared a post on X: "CF, DCF,…
Jun 12, 2024, 08:34 | Insight
Yakup Ergün: According to Petra Jagust et al. RET is crucial in the mechanism and etiology of BC brain metastases
Yakup Ergün, Medical Oncologist at Antalya City Hospital, recently shared a post on X: “RET…
Jun 3, 2024, 12:44 | Insight
Yakup Ergün: Adding LCT does not improve survival in oligometastatic NSCLC
Yakup Ergün, Medical Oncologist at Antalya City Hospital, recently shared a post on X: "NRG-LU002:…
Jun 2, 2024, 09:09 | Societies
15 Posts From ASCO24 Day 2 You Should Not Miss!
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held from May…
May 31, 2024, 17:02 | Insight
Yakup Ergün: A guide where we can find answers to every question about aBC
Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital, shared a post on…
May 28, 2024, 16:11 | Insight
Yakup Ergün: This is the most comprehensive review I have seen so far
Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital, shared a post on…
May 26, 2024, 13:42 | Insight
Some of the highlights while waiting for ASCO24 by Yakup Ergün
Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital, shared a post on…
May 26, 2024, 10:50 | Opinion
Yakup Ergün: The policy of some journals to collect accepted letters under a single heading is quite unfair
Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital, shared on X: “The policy…
May 26, 2024, 08:25 | Blog
Paolo Tarantino: Looking forward to presenting this analysis of T-DXd in 1500 patients with MBC
Paolo Tarantino shared a post by Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital,…
May 25, 2024, 01:35 | Insight
Yakup Ergün: An excellent review on the gonoadotoxicity of new anticancer agents
Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital, shared on X/Twitter: "Assessing risks…
May 23, 2024, 09:20 | Blog
Yakup Ergün Summarizes Final Results of RIGHT Choice
Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital, shared a post on X:…
May 21, 2024, 15:41 | Insight
Yakup Ergün: A valuable retrospective study on PD-L1 alteration after NAC in TNBC
Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital, shared a post on…
Apr 9, 2024, 09:20 | Insight
Yakup Ergün: Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases - SENOMAC trial
Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital, shared a post on…
Aug 14, 2023, 17:14 | Insight
Yakup Ergün: Breast-cancer screening gets a boost from Artificial Intelligence (AI)
In a Twitter post by Yakup Ergün, Medical Oncologist, it says: "Breast-cancer screening gets a…
All: 70 Posts: 1 - 100
Special Coverage